Canadian cannabis producer Canopy Growth Corp. reported a net loss of more than 128 million Canadian dollars ($95.7 million) in the first quarter of its fiscal year, with total revenue improving slightly on a quarterly basis as the company continues its corporate transformation plan.
Solomon Israel
Solomon Israel's Latest Posts
Canadian outdoor collective project misfires, offering lessons to other small cannabis growers
Canadian cannabis grower Mark Spear had a plan: Form an outdoor cannabis collective with some like-minded farmers, raise capital through equity crowdfunding and start growing high-quality outdoor flower in the Ottawa Valley region. Now, Spear's company, Wildfire...
Canadian cannabis firm Cronos posts $31.3M operating loss in Q2
Toronto-based cannabis company Cronos Group reported an adjusted operating loss of $31.3 million for its second quarter, along with $40 million worth of coronavirus-related impairment charges on its U.S. operations. Net revenue for the quarter...
Canada defers regulatory fee deadline for cannabis industry
Licensed Canadian cannabis companies are getting an extended deadline to pay an annual regulatory fee in light of disruptions caused by the COVID-19 pandemic. Federal cannabis license holders in their first full fiscal year or later fiscal years, which were required...
Struggling marijuana MSO iAnthus loses Chief Strategy Officer Stavola
Beth Stavola resigned as chief strategy officer and board director for troubled multistate cannabis operator iAnthus Capital Holdings. The company did not expound on the resignation of Stavola, who previously served as a senior vice president at Wall Street firm...
BC allows online payment for in-store cannabis pickup; is delivery next?
The province of British Columbia is allowing privately owned adult-use cannabis stores to accept payments online, by phone or through an app for in-store pickup - an effort to promote social distancing amid the COVID-19 pandemic. The amended...
Massachusetts allows sale of quarantined cannabis vape products
Massachusetts is ending its quarantine of marijuana-oil vapes, allowing resale and reclamation of those products provided they undergo new testing for heavy metals and vitamin E acetate, the additive blamed for the 2019 vaping-related health crisis. The quarantine was...
FDA approves GW Pharmaceuticals’ cannabis drug for new indication
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain's GW...
Nevada OKs partial settlement in marijuana licensing lawsuit
Nevada’s Tax Commission endorsed a partial settlement to resolve a consolidated lawsuit from a group of cannabis companies that claimed the state’s first round of recreational marijuana licensing was unfair.
Multistate marijuana operator Jushi upsizes debt financing to $33.3 million
Florida-based multistate marijuana and hemp operator Jushi Holdings increased a debt financing announced in late July by roughly $18 million, citing strong demand from shareholders and management.
Rhode Island governor to renew push for adult-use cannabis legalization
Rhode Island Gov. Gina Raimondo will continue trying to legalize adult-use marijuana in the state. She sees legal recreational sales as a possible revenue generator, she told Cranston TV station WJAR on Friday morning. "I was in favor of it...
FSD Pharma to surrender cannabis licenses, sell off marijuana assets
Canadian holding company FSD Pharma said it's exiting the marijuana business and relinquishing Health Canada cannabis licenses held by subsidiary FV Pharma. FSD Pharma CEO Raza Bokhari said the decision was made to maximize shareholder value...













